Researchers delivered GM-CSF mRNA to the endometrium using targeted nanoparticles. Implantation was restored in injured mouse ...

Bernstein 42nd Annual Strategic Decisions Conference May 28, 2026 10:00 AM EDTCompany ParticipantsStéphane Bancel - CEO ...

Creative Biogene is a dedicated research solutions provider focused on developing cutting-edge platforms for cancer therapy and preclinical studies. The team of seasoned scientists, bioinformatics ...

An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

Scribe Therapeutics, Inc. (Scribe), a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and ...

Researchers have identified how cells recognize and suppress transposons, mobile DNA elements that can destabilize genomes.

Korro is a biopharmaceutical company leveraging a novel oligonucleotide promoted editing of RNA (OPERA ®) platform to develop a new class of genetic medicines for rare and highly prevalent diseases.

Founded in 1848, Teikoku Seiyaku is dedicated to its mission “For a World Without Pain”, leveraging its expertise in transdermal absorption technology. Teikoku Seiyaku develops, manufactures, and ...

Hanzlik's multiple sclerosis was destroying her freedom to live the life she wanted. She gave up her active nursing job for a ...

What’s New and How It Affects Screening Recommendations for Americans The updated guidelines are a reminder that we ...

Oxford Nanopore Technologies PLC (LSE:ONT), the LSE-listed DNA sequencing company, has drawn positive reviews from RBC ...

Perth biotechs Avicena Systems and Syngenis Laboratories are fast-tracking pathogen detection technology to protect Australia ...